abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
91623: NeoCerebellar Degeneration Paraneoplastic Profile with Recombx® Print View
Summary Interpretation      
Interpretive Results Table      
Comments      

PRIMARY
1 Serum 2 (0.5) mL   Frozen - 28 Day(s)/Refrigerated - 28 Day(s)/Room Temperature - 72 Hour(s)  
ALTERNATE

Anti-CV2, anti-Hu, anti-Ma, anti-Ta, anti-Ri, anti-Yo, anti-Zic4 antibodies, and anti-GAD65 are found in patients with acute or subacute symptoms of cerebellar degeneration including gait ataxia, nystagmus and/or dysarthria, and opscolonus/myoclonus. This semi-quantitative assay maybe useful in monitoring therapeutic responses in selected cases.

Please label each specimen tube with two forms of patient
identification. These forms of identification must also appear on the
requisition form.
Serum must be separated from cells within 48 hours of collection.
Setup Schedule
Monday, Wednesday, Friday

Reported (Analytical Time)
7 days

CPT Codes
83520x7,86341

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Methodology: Automated Nanoliter Scale Immunoassay, Enzyme Linked Immunosorbent Assay

Transport Temperature: Refrigerated






© 1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database